DEVELOPMENT AND VALIDATION OF THE URINARY INCONTINENCE KINESIOPHOBIA SEVERITY SCALE
Development of the Kinesiophobia Severity Scale in Urinary Incontinence: A Validity and Reliability Study
This study aims to develop and validate a novel Turkish-language self-report instrument, the Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI), to assess movement avoidance and fear of movement associated with concerns about urinary leakage in individuals with urinary incontinence. Following scale development, its validity and reliability will be evaluated through psychometric analyses in accordance with the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) recommendations.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
This methodological study aims to develop and evaluate the validity and reliability of the Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI), a novel Turkish-language self-report instrument designed to assess fear of movement and movement avoidance associated with concerns about urinary leakage.
The study will include individuals with urinary incontinence, including stress, urgency, and mixed urinary incontinence. Participants will be recruited exclusively from individuals reporting urinary incontinence among relatives of patients attending the Physical Therapy and Rehabilitation Center. Individuals who meet the eligibility criteria and voluntarily agree to participate will be enrolled in the study. Written informed consent will be obtained from all participants before data collection.
Initially, an item pool was developed through a comprehensive literature review, semi-structured interviews with 15-20 individuals with urinary incontinence, and recommendations from experts in relevant clinical disciplines. Following ethical approval, the items will undergo content validity assessment by a multidisciplinary panel of at least 10 experts. Item relevance, clarity, simplicity, and necessity will be evaluated using the Content Validity Ratio (CVR), Content Validity Index (CVI), and modified kappa statistics.
Subsequently, face validity and comprehensibility will be assessed through cognitive interviews with 8-12 individuals. Items will be revised based on participant feedback. Pilot testing will be conducted to examine item distributions, floor and ceiling effects, corrected item-total correlations, internal consistency, and item discrimination.
Following these preliminary evaluations, the revised scale will be administered to eligible participants during a single assessment session. Questionnaire completion is expected to take approximately 15-20 minutes.
Psychometric analyses will be performed to evaluate the validity and reliability of the scale. Based on the findings, the final scale will be established, and a scoring and interpretation guide will be developed.
The study is expected to provide a valid and reliable instrument for assessing urinary incontinence-related kinesiophobia and contribute to the evaluation of movement-related fear and avoidance behaviors in individuals with urinary incontinence.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Esra BAYRAMOĞLU DEMİRDÖĞEN
- Numéro de téléphone: 05426961169
- E-mail: esra.bayramoglu@ahievran.edu.tr
Sauvegarde des contacts de l'étude
- Nom: Esra BAYRAMOĞLU DEMİRDÖĞEN
- Numéro de téléphone: 5426961169
- E-mail: esra.bayramoglu@ahievran.edu.tr
Lieux d'étude
-
-
Kırşehir
-
Kırşehir, Kırşehir, Turquie (Türkiye), 40100
- Recrutement
- Kırşehir Ahi Evran Üniversitesi
-
Contact:
- Esra BAYRAMOĞLU DEMİRDÖĞEN
- E-mail: esra.bayramoglu@ahievran.edu.tr
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
The study population will consist of adults aged 18 years or older who report urinary incontinence, including stress, urgency, and mixed urinary incontinence. Participants will be recruited from among relatives of patients attending the Physical Therapy and Rehabilitation Center. Eligible individuals who report urinary leakage at least once per week during the past three months, are able to read and understand Turkish, and voluntarily agree to participate will be included in the study. Individuals with active lower urinary tract infections or conditions that prevent independent completion of the questionnaires will be excluded.
La description
Inclusion Criteria:
- Being 18 years of age or older
- Reporting symptoms of incontinence at least once a week for the past 3 months (ICIQ-SF score ≥ 1)
- Having the ability to read and comprehend Turkish
- Having been informed about the study and provided written informed consent
Exclusion Criteria:
- Having an active lower urinary tract infection
- Inability to complete the scales independently due to cognitive impairment, advanced dementia, or limited literacy
- Individuals who refuse to participate in the study or do not sign the informed consent form
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: CASE_ONLY
- Perspectives temporelles: CROSS_SECTIONAL
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Incontinance
This group will consist of individuals with urinary incontinence, including stress, urgency, and mixed urinary incontinence, who are recruited from among relatives of patients attending the Physical Therapy and Rehabilitation Center. Eligible participants who voluntarily agree to participate will complete the newly developed Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI) to assess fear of movement and movement avoidance associated with concerns about urinary leakage. The scale will undergo psychometric evaluation to assess its validity and reliability. No therapeutic intervention will be administered as part of the study. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Content Validity of the Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI)
Délai: During the initial expert evaluation, before participant recruitment for the main validation study.
|
The content validity of the newly developed scale will be evaluated by a multidisciplinary panel of at least 10 experts. Item relevance, clarity, simplicity, and necessity will be assessed using the Content Validity Ratio (CVR), Item-level Content Validity Index (I-CVI), Scale-level Content Validity Index (S-CVI), and modified kappa statistics. |
During the initial expert evaluation, before participant recruitment for the main validation study.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Internal Consistency of the KSS-UI
Délai: Baseline (single assessment session; approximately 15-20 minutes).
|
The internal consistency of the KSS-UI will be evaluated using Cronbach's alpha coefficient and corrected item-total correlations. The contribution of individual items to scale reliability will also be examined. |
Baseline (single assessment session; approximately 15-20 minutes).
|
|
Item Discrimination and Item Performance of the KSS-UI
Délai: Baseline (single assessment session; approximately 15-20 minutes).
|
Item performance will be evaluated by examining item distributions, floor and ceiling effects, and corrected item-total correlations. Item discrimination will be assessed by comparing item scores between the upper and lower 27% of participants based on total scale scores. |
Baseline (single assessment session; approximately 15-20 minutes).
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Esra BAYRAMOĞLU DEMİRDÖĞEN, Kırşehir Eğitim ve Araştırma Hastanesi
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- KAEU-EBAYRAMOGLUD-010
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Individual participant data will not be shared to protect participants' privacy and confidentiality, given the sensitive nature of urinary incontinence-related health information. Study findings will be reported in aggregate form.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .